Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125984221 | 12598422 | 1 | I | 201503 | 20160718 | 20160726 | 20160726 | EXP | FR-ASTRAZENECA-2016SE79319 | ASTRAZENECA | 66.00 | YR | M | Y | 0.00000 | 20160726 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125984221 | 12598422 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5480 | MG | Y | U | 21366 | 5 | MG | TABLET | QD | |||
| 125984221 | 12598422 | 2 | SS | XYLOCAINE NAPHAZOLINE | LIDOCAINE HYDROCHLORIDENAPHAZOLINE NITRATE | 1 | Oral | 0 | |||||||||||
| 125984221 | 12598422 | 3 | SS | DETENSIEL | BISOPROLOL FUMARATE | 1 | Oral | 10960 | MG | 0 | 10 | MG | QD | ||||||
| 125984221 | 12598422 | 4 | SS | TENSTATEN | CICLETANINE HYDROCHLORIDE | 1 | Oral | 54800 | MG | 0 | 50 | MG | QD | ||||||
| 125984221 | 12598422 | 5 | C | OMEXEL | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4MG UNKNOWN | 0 | .4 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125984221 | 12598422 | 1 | Dyslipidaemia |
| 125984221 | 12598422 | 3 | Hypertension |
| 125984221 | 12598422 | 4 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125984221 | 12598422 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125984221 | 12598422 | Off label use | |
| 125984221 | 12598422 | Oral mucosa erosion | |
| 125984221 | 12598422 | Pemphigus | |
| 125984221 | 12598422 | Product use issue | |
| 125984221 | 12598422 | Pulmonary mass | |
| 125984221 | 12598422 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125984221 | 12598422 | 1 | 2013 | 201603 | 0 | |
| 125984221 | 12598422 | 2 | 20160608 | 0 | ||
| 125984221 | 12598422 | 3 | 2013 | 0 | ||
| 125984221 | 12598422 | 4 | 2013 | 0 | ||
| 125984221 | 12598422 | 5 | 201603 | 0 |